Xenitra Limited to Host Investor Webinar Featuring Non-Executive Director Anthony Noble on 30 July 2026

Xenitra’s FMCG and Nutraceutical Distribution Strategy in China

Xenitra Limited specialises in distributing fast-moving consumer goods (FMCG), nutraceuticals, over-the-counter medicines, and personal care products. The company’s business model revolves around a channel-optimised sales ecosystem that integrates blockchain-enabled tokenised distribution channels. This model encompasses Business-to-Business (B2B) trading, retail distribution, and ecommerce platforms, creating a diversified network to reach various customer segments across China. The company’s strategic emphasis on Chinese markets targets the robust growth potential in FMCG and health supplement sectors there.

Xenitra’s operational infrastructure includes ecommerce and livestream commerce platforms, which have become essential sales channels in China. These digital platforms are supported by traditional distributor networks, ensuring broad market reach and redundancy. The company serves Australian and international brands aiming to enter or expand within the Chinese FMCG market. This multi-channel approach is designed to offer scalability and adaptability as market conditions evolve.

Real World Asset Tokenisation: A Market Differentiator

Xenitra is among the first Australian companies to implement Real World Asset (RWA) tokenisation integrated into mainstream FMCG sales channels in China. This blockchain innovation distinguishes Xenitra’s market offering by bridging conventional consumer goods distribution with emerging digital asset technologies. The integration provides unique value propositions to suppliers and distributors within its ecosystem.

RWA tokenisation in FMCG distribution is a novel commercial application, especially in the Chinese market. The technology enhances transparency, traceability, and efficiency throughout the distribution chain. It also enables fractional ownership, improved logistics tracking, and streamlined settlements in B2B trading. However, adoption depends on regulatory developments in Australia and China, as well as market demand and acceptance by brands and distributors.

The OPAL Ecosystem and Growth Strategy for International Brands

Xenitra’s OPAL ecosystem serves as a platform for onboarding new international and domestic brands into its distribution network. Leveraging ecommerce, livestream commerce, and distributor infrastructure across China and Australia, OPAL simplifies market entry and expansion for brands. This technology-enabled distribution platform reduces complexity and accelerates scaling by integrating new brands into existing channels.

With a presence in both Australian and Chinese markets, the OPAL ecosystem facilitates cross-border commerce and market access. Established relationships with local distributors and ecommerce partners allow brands to bypass developing independent networks. This platform-as-a-service model generates revenue through distribution, transaction fees, and technology services. Maintaining operational efficiency and managing multi-jurisdictional regulations are key to scaling success.

Enhancing Shareholder Engagement Through Investor Webinar

The upcoming investor webinar underscores Xenitra’s commitment to transparent communication with shareholders and market participants. Featuring Non-Executive Director Anthony Noble, the session offers a direct channel to discuss recent developments and strategic initiatives. Such webinars are vital for addressing investor questions, clarifying company direction, and sustaining confidence. The timing indicates material updates warranting detailed discussion.

Having a Non-Executive Director lead the presentation highlights governance emphasis on independent oversight. Anthony Noble will expand on multiple recent announcements, providing shareholders with firsthand insights into the company’s performance and future plans. The webinar is a valuable opportunity for investors to engage directly with company leadership and make informed decisions.

Recent Strategic Developments Driving Investor Interest

While the company has not detailed the specific "recent announcements," the webinar suggests significant developments such as strategic partnerships, revenue milestones, product launches, market expansion, or technological advancements related to the OPAL ecosystem or RWA tokenisation. Management’s decision to host a live presentation reflects confidence in these positive developments and a desire for open investor dialogue.

The interactive webinar format enables real-time shareholder engagement, allowing the company to address questions and provide additional context beyond prior disclosures. Investors seeking a deeper understanding of Xenitra’s strategic direction will find this session informative.

China-Centric Market Exposure and Operational Risks

Xenitra’s core operations focus on the Chinese market, utilizing ecommerce, livestream commerce, and distributor networks for FMCG and nutraceutical products. China’s vast and dynamic consumer market, with rapid growth in online commerce, offers significant opportunities. Livestream shopping is particularly popular, positioning Xenitra to benefit from expanding digital consumer spending.

However, heavy reliance on China exposes Xenitra to risks including political and regulatory changes, economic fluctuations, shifting consumer behaviors, and evolving policies toward foreign firms and blockchain technologies. The competitive FMCG distribution landscape requires Xenitra to maintain pricing, quality, and service advantages. Navigating regulatory environments in both Australia and China, especially for cross-border commerce and blockchain applications, remains critical.

Regulatory Challenges Surrounding Blockchain and RWA Tokenisation

Xenitra’s blockchain-enabled RWA tokenisation integration introduces innovation alongside regulatory and operational uncertainties. Global blockchain and cryptocurrency regulations are evolving, with Australian and Chinese authorities exercising caution. Regulatory scrutiny could impact the company’s technology infrastructure or business model.

The commercial adoption of RWA tokenisation in FMCG distribution is still emerging. Market acceptance depends on proven value, ease of integration, and regulatory clarity. Potential restrictions or stringent regulations could impair Xenitra’s technological edge. Success relies on maintaining compliance and strong relationships with regulators in both countries.

Investor Registration Details and Webinar Participation

Shareholders and investors interested in attending must register via the Zoom link provided by Xenitra. The webinar is scheduled for Thursday, 30 July 2026 at 11:00am AEST. Attendees in other time zones should adjust accordingly, as the timing may be early evening or late night in regions like Western Europe and the Americas. The registration link is publicly accessible to facilitate global participation.

For further information or questions about the webinar, investors can contact Harry Spillane at Blackwater Advisors via phone (+61 447 757 550) or email ([email protected]). This dedicated investor relations contact supports shareholder engagement and reflects Xenitra’s commitment to professional communication.

Corporate Headquarters and ASX Listing

Xenitra Limited is headquartered at 270 Adelaide Street, Brisbane, Queensland 4000, establishing its base in one of Australia’s key business hubs. The company is publicly listed on the Australian Securities Exchange under ticker XEN (ACN: 150 110 017), subject to ASX Listing Rules and ASIC oversight. This structure ensures regulatory transparency and access to institutional investors.

Being ASX-listed offers capital raising advantages but also entails continuous disclosure, governance, and reporting obligations. The Brisbane location provides access to business infrastructure and professional services supporting operations and compliance. Xenitra’s corporate framework reflects its status as an established Australian company with significant international operations, particularly in China.